🔗 Permalink

Inventor profile of:

Jan Grimm

City:

Dubendorf

Country:

Switzerland

Published Applications:

63

Last publication date:

2025-05-15

Top Assignees for applications by Jan Grimm

The entities that hold a legal rights for patent applications filed by inventor Grimm Jan:

UNIVERSITY OF ZURICH 22 Zurich, Switzerland
NEURIMMUNE HOLDING AG 19 Schlieren, Switzerland
Biogen International Neuroscience GmbH 13 Zug, Switzerland
Biogen International Neuroscience GmbH 7 Baar, Switzerland
BIOGEN MA INC. 5 Cambridge, MA United States
BIOGEN IDEC INTERNATIONAL NEUROSCIENCE GMBH 4 Schlieren, Switzerland
NEW YORK UNIVERSITY 2 New York, NY United States
Neurimmune Holding AG 2 , Switzerland
University of Zurich 2 , Switzerland
Neurimmune AG 1 Schlieren, Switzerland
BIOGEN IDEC INTERNALTIONAL NEUROSCIENCE GMBH 1 Schlieren, Switzerland
Mabimmune Diagostics AG 1 Schlieren, Switzerland
The University of Zurich 1 Zurich, Switzerland
Neurimmunie Holding AG 1 Schlieren, Switzerland

Recent patent applications by Grimm Jan

Jan Grimm from Dubendorf, CH has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-05-15

US20250154235A1

Chemistry; metallurgy

ANTIBODY-BASED THERAPY OF TRANSTHYRETIN (TTR) AMYLOIDOSIS AND HUMAN-DERIVED ANTIBODIES THEREFOR

#2 | 2025-05-08

US20250145699A1

Chemistry; metallurgy

ANTIBODY-BASED THERAPY OF TRANSTHYRETIN (TTR) AMYLOIDOSIS AND HUMAN-DERIVED ANTIBODIES THEREFOR

#3 | 2024-08-22

US20240279361A1

Chemistry; metallurgy

HUMAN-DERIVED ANTI-DIPEPTIDE REPEATS (DPRS) ANTIBODY

#4 | 2024-08-01

US20240254256A1

Chemistry; metallurgy

Human Anti-SOD1 Antibodies

#5 | 2024-03-28

US20240101654A1

Chemistry; metallurgy

HUMAN ANTI-TAU ANTIBODIES

#6 | 2023-09-14

US20230287106A1

Chemistry; metallurgy

NOVEL COMPOUNDS CAPABLE OF ANTAGONIZING ISLET AMYLOID POLYPEPTIDE (IAPP) INDUCED BETA-CELL DAMAGE AND IMPAIRED GLUCOSE TOLERANCE

#7 | 2023-08-03

US20230242624A1

Chemistry; metallurgy

HUMAN ANTIBODIES AGAINST SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2 (SARS-CoV-2)

#8 | 2023-06-15

US20230183329A1

Chemistry; metallurgy

COMBINATION THERAPY FOR TTR AMYLOIDOSIS

#9 | 2023-02-02

US20230035402A1

MISFOLDED SOD1 ASSAY

#10 | 2022-12-22

US20220403011A1

Chemistry; metallurgy

METHOD OF PROVIDING DISEASE-SPECIFIC BINDING MOLECULES AND TARGETS

#11 | 2022-10-20

US20220332808A1

Chemistry; metallurgy

HUMAN-DERIVED ANTI-HUNTINGTIN (HTT) ANTIBODIES AND USES THEREOF

#12 | 2022-08-25

US20220267471A1

Chemistry; metallurgy

Human Anti-SOD1 Antibodies

#13 | 2022-05-19

US20220153874A1

Chemistry; metallurgy

Human-derived anti-(poly-GA) dipeptide repeat (DPR) antibody

#14 | 2022-05-12

US20220144928A1

Chemistry; metallurgy

Antibody-based therapy of transthyretin (TTR) amyloidosis and human-derived antibodies therefor

#15 | 2021-12-30

US20210400932A1

Human necessities

PATIENT-DERIVED AMYLOID XENOGRAFT NON-HUMAN ANIMAL MODEL

#16 | 2021-11-25

US20210361754A1

Human necessities

METHOD OF PROVIDING PATIENT SPECIFIC IMMUNE RESPONSE IN AMYLOIDOSES AND PROTEIN AGGREGATION DISORDERS

#17 | 2021-08-05

US20210238265A1

Chemistry; metallurgy

Human Anti-Tau Antibodies

#18 | 2021-04-15

US20210107972A1

Chemistry; metallurgy

HUMAN ISLET AMYLOID POLYPEPTIDE (HIAPP) SPECIFIC ANTIBODIES AND USES THEREOF

#19 | 2020-12-17

US20200392217A1

Chemistry; metallurgy

Human-derived anti-huntingtin (HTT) antibodies and uses thereof

#20 | 2020-08-20

US20200262895A1

Chemistry; metallurgy

HUMAN ANTI-TAU ANTIBODIES

#21 | 2020-07-23

US20200231667A1

Chemistry; metallurgy

NOVEL COMPOUNDS CAPABLE OF ANTAGONIZING ISLET AMYLOID POLYPEPTIDE (IAPP) INDUCED BETA-CELL DAMAGE AND IMPAIRED GLUCOSE TOLERANCE

#22 | 2020-03-05

US20200071390A1

Chemistry; metallurgy

Recombinant human antibodies for therapy and prevention of polyomavirus-related diseases

#23 | 2020-01-16

US20200017577A1

Chemistry; metallurgy

TDP-43 specific binding molecules

#24 | 2020-01-09

US20200010567A1

Chemistry; metallurgy

Human-derived anti-dipeptide repeats (DPRs) antibody

#25 | 2019-11-14

US20190345237A1

Chemistry; metallurgy

Antibody-based therapy of transthyretin (TTR) amyloidosis and human-derived antibodies therefor

#26 | 2019-09-19

US20190284302A1

Chemistry; metallurgy

Human anti-SOD1 antibodies

#27 | 2019-08-01

US20190233506A1

Chemistry; metallurgy

Human Anti-Tau Antibodies

#28 | 2019-06-06

US20190169274A1

Chemistry; metallurgy

HUMAN ANTI-TAU ANTIBODIES

#29 | 2019-03-28

US20190094245A1

Use of an Anti-Alpha-Synuclein Antibody to Diagnose an Elevated Level of Alpha-Synuclein in the Brain

#30 | 2018-12-27

US20180371065A1

Chemistry; metallurgy

Human anti-alpha-synuclein antibodies

#31 | 2018-12-13

US20180355027A1

Chemistry; metallurgy

Anti-alpha synuclein binding molecules

#32 | 2018-12-06

US20180346558A1

Chemistry; metallurgy

Human islet amyloid polypeptide (hIAPP) specific antibodies and uses thereof

#33 | 2018-06-28

US20180179276A1

Chemistry; metallurgy

Compounds capable of antagonizing islet amyloid polypeptide (IAPP) induced beta-cell damage and impaired glucose tolerance

#34 | 2018-04-26

US20180110845A1

Human necessities

Method of providing patient specific immune response in amyloidoses and protein aggregation disorders

#35 | 2018-02-08

US20180037635A1

Chemistry; metallurgy

Recombinant human antibodies for therapy and prevention of polyomavirus-related diseases

#36 | 2018-01-25

US20180022822A1

Chemistry; metallurgy

NOVEL ANTI-FIBROBLAST ACTIVATION PROTEIN (FAP) BINDING AGENTS AND USES THEREOF

#37 | 2018-01-11

US20180011112A1

Use of an Anti-Alpha-Synuclein Antibody to Diagnose an Elevated Level of Alpha-Synuclein in the Brain

#38 | 2018-01-04

US20180002409A1

Chemistry; metallurgy

Human Anti-Tau Antibodies

#39 | 2017-12-28

US20170369592A1

Chemistry; metallurgy

NOVEL ANTI-FIBROBLAST ACTIVATION PROTEIN (FAP) ANTIBODIES AND USES DERIVED THEREOF

#40 | 2017-12-28

US20170369560A1

Chemistry; metallurgy

HUMAN ANTI-TAU ANTIBODIES

#41 | 2017-08-31

US20170247471A1

Chemistry; metallurgy

Human-derived anti-dipeptide repeats (DPRs) antibody

#42 | 2017-08-17

US20170233463A1

Chemistry; metallurgy

Anti-alpha synuclein binding molecules

#43 | 2017-06-15

US20170166631A1

Chemistry; metallurgy

Human derived anti-Huntingtin (HTT) antibodies and uses thereof

#44 | 2017-06-01

US20170152308A1

Chemistry; metallurgy

TDP-43 specific binding molecules

#45 | 2016-12-29

US20160376354A1

Chemistry; metallurgy

Human islet amyloid polypeptide (HIAPP) specific antibodies and uses thereof

#46 | 2016-12-08

US20160355576A1

Chemistry; metallurgy

Antibody-based therapy of transthyretin (TTR) amyloidosis and human-derived antibodies therefor

#47 | 2016-12-08

US20160354451A1

Human necessities

METHOD OF PROVIDING PATIENT SPECIFIC IMMUNE RESPONSE IN AMYLOIDOSES AND PROTEIN AGGREGATION DISORDERS

#48 | 2016-06-16

US20160168267A1

Chemistry; metallurgy

Human anti-SOD1 antibodies

#49 | 2016-02-25

US20160052996A1

Chemistry; metallurgy

Recombinant human antibodies for therapy and prevention of polyomavirus-related diseases

#50 | 2015-12-03

US20150344553A1

Chemistry; metallurgy

Human anti-tau antibodies

#51 | 2015-11-05

US20150315267A1

Chemistry; metallurgy

A METHOD OF REDUCING BRAIN AMYLOID PLAQUES USING ANTI-AB ANTIBODIES

#52 | 2015-09-10

US20150252102A1

Chemistry; metallurgy

Human anti-tau antibodies

#53 | 2015-07-30

US20150210759A1

Chemistry; metallurgy

Human islet amyloid polypeptide (hIAPP) specific antibodies and uses thereof

#54 | 2014-12-18

US20140369940A1

Chemistry; metallurgy

Anti-α synuclein binding molecules

#55 | 2014-10-09

US20140301945A1

Human necessities

Human anti-SOD1 antibodies

#56 | 2014-10-02

US20140295465A1

USE OF AN ANTI-alpha-SYNUCLEIN ANTIBODY TO DIAGNOSE AN ELEVATED LEVEL OF alpha-SYNUCLEIN IN THE BRAIN

#57 | 2014-09-11

US20140255304A1

Chemistry; metallurgy

TDP-43 specific binding molecules

#58 | 2014-02-13

US20140044644A1

Human necessities

ANKYRIN G AND MODULATORS THEREOF FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS

#59 | 2012-04-12

US20120087861A1

Chemistry; metallurgy

Human anti-tau antibodies

#60 | 2010-11-25

US20100297108A1

Human necessities

Method of providing patient specific immune response in amyloidoses and protein aggregation disorders

#61 | 2010-07-08

US20100172919A1

Human necessities

NOVELTREATMENT FOR NEUROLOGICAL DISORDERS

#62 | 2010-07-01

US20100169988A1

MEANS AND METHODS FOR ISOLATING AND DETERMINING NOVEL TARGETS FOR THE TREATMENT OF NEURODEGENERATIVE, NEUROLOGICAL OR NEUROPSYCHIATRIC DISORDERS AND COMPOSITIONS COMPRISING THE SAME

#63 | 2009-05-07

US20090117120A1

Chemistry; metallurgy

Transgenic animal model for alzheimer's disease

InventorID:

649723 ⎘